Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ziqin Yan

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Heliyon|August 30, 2019
Stock selection with random forest: An exploitation of excess return in the Chinese stock marketZheng Tan, Ziqin Yan, Guangwei Zhu
Clinics (Sao Paulo, Brazil)|June 30, 2026
Effects of platelet-rich fibrin combined with hydroxyapatite in the treatment of patients with periodontal intrabony defects: a meta-analysisLuyue Li, Tian Liu, Ziqin Yan, et al.
Sensors (Basel, Switzerland)|March 14, 2026
AF-CuRL: Stable Reinforcement Learning for Resource-Constrained Long-Form Reasoning in Edge-Intelligent SystemsZiqin Yan, Yurong Wang, Qingsheng Yue, et al.
Medchemcomm|August 16, 2018
Allenamide as a bioisostere of acrylamide in the design and synthesis of targeted covalent inhibitorsDeheng Chen, Dexiang Guo, Ziqin Yan, et al.
Journal of Medicinal Chemistry|July 21, 2021
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein InteractionsShiyan Zhang, Jianfeng Lou, Yafang Li, et al.
European Journal of Medicinal Chemistry|September 5, 2022
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunitiesJianfeng Lou, Yuhang Lu, Jing Cheng, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Design, Construction, and Screening of Diversified Pyrimidine-Focused DNA-Encoded LibrariesMengnisa Seydimemet, Yixuan Yang, Yuhan Lv, et al.
Journal of Medicinal Chemistry|April 14, 2022
Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer CellsShiyan Zhang, Ziqin Yan, Yafang Li, et al.
European Journal of Medicinal Chemistry|April 21, 2023
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell linesZiqin Yan, Xilin Lyu, Dongze Lin, et al.
Journal of Medicinal Chemistry|January 13, 2025
Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In VivoYuhang Lu, Ziqin Yan, Jiaqi Sun, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Heliyon|August 30, 2019
Stock selection with random forest: An exploitation of excess return in the Chinese stock marketZheng Tan, Ziqin Yan, Guangwei Zhu
Clinics (Sao Paulo, Brazil)|June 30, 2026
Effects of platelet-rich fibrin combined with hydroxyapatite in the treatment of patients with periodontal intrabony defects: a meta-analysisLuyue Li, Tian Liu, Ziqin Yan, et al.
Sensors (Basel, Switzerland)|March 14, 2026
AF-CuRL: Stable Reinforcement Learning for Resource-Constrained Long-Form Reasoning in Edge-Intelligent SystemsZiqin Yan, Yurong Wang, Qingsheng Yue, et al.
Medchemcomm|August 16, 2018
Allenamide as a bioisostere of acrylamide in the design and synthesis of targeted covalent inhibitorsDeheng Chen, Dexiang Guo, Ziqin Yan, et al.
Journal of Medicinal Chemistry|July 21, 2021
Recent Progress and Clinical Development of Inhibitors that Block MDM4/p53 Protein-Protein InteractionsShiyan Zhang, Jianfeng Lou, Yafang Li, et al.
European Journal of Medicinal Chemistry|September 5, 2022
A chemical perspective on the modulation of TEAD transcriptional activities: Recent progress, challenges, and opportunitiesJianfeng Lou, Yuhang Lu, Jing Cheng, et al.
ACS Medicinal Chemistry Letters|August 16, 2023
Design, Construction, and Screening of Diversified Pyrimidine-Focused DNA-Encoded LibrariesMengnisa Seydimemet, Yixuan Yang, Yuhan Lv, et al.
Journal of Medicinal Chemistry|April 14, 2022
Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer CellsShiyan Zhang, Ziqin Yan, Yafang Li, et al.
European Journal of Medicinal Chemistry|April 21, 2023
Selective degradation of cellular BRD3 and BRD4-L promoted by PROTAC molecules in six cancer cell linesZiqin Yan, Xilin Lyu, Dongze Lin, et al.
Journal of Medicinal Chemistry|January 13, 2025
Selective Degradation of TEADs by a PROTAC Molecule Exhibited Robust Anticancer Efficacy In Vitro and In VivoYuhang Lu, Ziqin Yan, Jiaqi Sun, et al.
Pageof 3